A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

NCT00934375 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: Aricept (donepezil hydrochloride)
DRUG: placebo

Sponsor

Eisai Inc.